Ignite Creation Date:
2024-05-06 @ 8:06 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02668653
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2016-01-22
Brief Title:
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD Acute Myeloid Leukemia AML
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-22
First Submit QC Date:
January 28 2016
Study First Post Date:
2016-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-02
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL